138407-63-3

Upstream product

• 138407-80-4 (2R*,3S*)-3-(benzoyloxy)-2-phenyl-2,3-dihydro-4H-pyran-4-one 
• 100-52-7 benzaldehyde 
• 108-05-4 vinyl acetate 
• 138512-01-3 (2R*,3R*,4R*)-3-(benzoyloxy)-4-hydroxy-2-phenyl-2,3-dihydro-4H-pyran 

Downstream Products

• 138512-16-0 (-)-(2R,3R,4R)-3,4-dihydroxy-2-phenyl-2,3-dihydro-4H-pyran 
• 138432-66-3 (-)-(2R,3S,4R)-2-phenyl-3,4-bis<(trimethylsilyl)oxy>-2,3-dihydro-4H-pyran 
• 138407-83-7 (2'S,3'S,4'S,5'S,6'R)-7-O-<2'-<3'-iodo-6'-phenyl-4',5'-bis<(trimethylsilyl)oxy>tetrahydropyranosyl>>daunomycinone 
• 138407-83-7 (8S,10S)-8-Acetyl-6,8,11-trihydroxy-10-((2S,3R,4S,5S,6R)-3-iodo-6-phenyl-4,5-bis-trimethylsilanyloxy-tetrahydro-pyran-2-yloxy)-1-methoxy-7,8,9,10-tetrahydro-naphthacene-5,12-dione 
• 138407-83-7 (8S,10S)-8-Acetyl-6,8,11-trihydroxy-10-((2R,3R,4S,5S,6R)-3-iodo-6-phenyl-4,5-bis-trimethylsilanyloxy-tetrahydro-pyran-2-yloxy)-1-methoxy-7,8,9,10-tetrahydro-naphthacene-5,12-dione 

Relevant academic research and scientific papers

A route to artificial glycoconjugates and oligosaccharides via enzymatically resolved glycals: Dramatic effects of the handedness of the sugar domain upon the properties of an anthracycline drug

Racemic, fully synthetic glycals of considerable structural variety may be kinetically resolved via enzymatically mediated transesterification using Lipase PS-30 from Pseudomonas cepacia as catalyst and vinyl acetate as acyl donor. This methodology provid

Enzymatic resolution of racemic glycals: An application of the wong acylation method

Kinetic resolution of racemic, fully synthetic, artificial glycals bearing a free hydroxyl group at C3 was accomplished through the more rapid acylation of the 'D'-antipode with vinyl acetate as acyl donor and Lipase PS-30 from Pseudomonas cepa